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Abstract
Background. It is estimated that disease burden due to low fruit and vegetable consumption is higher in Central and
Eastern Europe (CEE) and the former Soviet Union (FSU) than any other parts of the world. However, no large scale
studies have investigated the association between fruit and vegetable (F&V) intake and mortality in these regions yet.
Design. The Health, Alcohol and Psychosocial Factors in Eastern Europe (HAPIEE) study is a prospective cohort study
with participants recruited from the Czech Republic, Poland and Russia.
Methods. Dietary data was collected using food frequency questionnaire. Mortality data was ascertained through linkage
with death registers. Multivariable adjusted hazard ratios were calculated by Cox regression models.
Results. Among 19,333 disease-free participants at baseline, 1314 died over the mean follow-up of 7.1 years. After
multivariable adjustment, we found statistically significant inverse association between cohort-specific quartiles of F&V
intake and stroke mortality: the highest vs lowest quartile hazard ratio (HR) was 0.52 (95% confidence interval (CI):
0.28–0.98). For total mortality, significant interaction (p¼ 0.008) between F&V intake and smoking was found. The
associations were statistically significant in smokers, with HR 0.70 (0.53–0.91, p for trend: 0.011) for total mortality,
and 0.62 (0.40–0.97, p for trend: 0.037) for cardiovascular disease (CVD) mortality. The association was appeared to be
mediated by blood pressure, and F&V intake explained a considerable proportion of the mortality differences between
the Czech and Russian cohorts.
Conclusions. Our results suggest that increasing F&V intake may reduce CVD mortality in CEE and FSU, particularly
among smokers and hypertensive individuals.
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Introduction
A number of observational epidemiological studies
have found inverse associations between fruit and vege-
table (F&V) intake and the risk of cardiovascular dis-
ease (CVD), coronary heart disease (CHD) and
stroke.1–4 The mechanisms how F&V intake might
reduce disease risk are not entirely clear; while the anti-
oxidant hypothesis was not confirmed,5 blood pressure
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lowering effect of F&V consumption, confirmed in
experimental trials, seems to be an important
mediator.6
Although most studies of F&V intake and CVD
have been carried out in Western European or North
American populations, low F&V consumption has been
suggested to be one of the reasons for the high CVD
mortality rates in countries of Central and Eastern
Europe (CEE) and the former Soviet Union (FSU).7,8
The World Health Organisation (WHO) Global
Burden of Disease (GBD) project has estimated that
the disease burden due to inadequate F&V consump-
tion is higher in CEE/FSU than any other parts of the
world.9 Despite this indirect evidence, reliable indivi-
dual-level dietary data in CEE and FSU countries are
scarce and, to date, no well-powered studies of F&V
intakes in relation to CVD have been reported in the
region.
In this study, we investigated the relationship
between F&V intake and mortality from all-causes,
CVD, CHD and stroke in three populations participat-
ing in the Health, Alcohol and Psychosocial Factors in
Eastern Europe (HAPIEE) project,10 the largest cohort
study with population data on dietary habits in CEE
and FSU. As secondary objectives, we examined the
potential mediating role of blood pressure, and whether
F&V intake explained any of the mortality differences
between the study populations.
Methods
Subjects
Between 2002–2005, 28,945 middle-aged man and
women, randomly selected from population/electoral
registers in Krakow (Poland), Novosibirsk (Russia)
and six cities of the Czech Republic (Havı́řov/
Karviná, Jihlava, Ústı́ nad Labem, Liberec, Hradec
Králové, and Kroměřı́z), were recruited for the
HAPIEE study. The overall response rate was 59%.10
Participants completed an extensive questionnaire, pro-
vided a blood sample and underwent a medical exam-
ination. Written informed consent was provided by all
participants, and the study protocols were approved by
ethical committees at University College London and
all participating centres.
Individuals whose mortality data was not available
(n¼ 1048), provided implausible dietary data (partici-
pants in the lowest and highest 1% of the energy intake
vs basal metabolic rate ratio distribution) (n¼ 548), had
not answered more than 10% of the questions on the
food frequency questionnaire (FFQ) (n¼ 685) or had
indicated that the FFQ was not representative to their
diet (n¼ 806) were excluded from the analysis.
Similarly, those with previously diagnosed CVD or
diabetes (n¼ 6525) were also excluded. After these
exclusions, 19,333 participants (5967 Czech, 6543
Polish and 6823 Russian) were included in the analysis.
Dietary assessment
Dietary data collection in HAPIEE study has been
described in detail elsewhere.11 Briefly, a food fre-
quency questionnaire (FFQ) was used to assess the par-
ticipants’ eating habits in the previous three months.
The Czech, Polish and Russian questionnaires con-
sisted of 136, 148 and 147 food and drink items,
respectively.
The European Food Safety Authority‘s FoodEx 2
food classification and description system was used to
categorise food items into fruit and vegetable food
groups.12 All items which are listed in the group of
‘fresh fruits’ (A04RK) or ‘vegetable and vegetable
products’ (A00FJ), with the exception of ‘vegetable
products’ (A00ZA), were considered as fruits and vege-
tables. Overall, 21 fruit and 24 vegetable items were
included (Supplementary Material, Table S1).
Participants indicated how frequently they con-
sumed a portion of a particular food item on a nine-
point scale. Daily consumption of the different F&V
items were calculated by multiplying the number of
portions per day by average portion sizes determined
by local dieticians. A person’s daily F&V consumption
was calculated by adding up the intake values of the
different items.
As self-reported dietary intakes are often imprecise,
we assessed the validity of F&V intake data against
plasma biomarker concentrations, measured in a
random sub-sample of participants in all three coun-
tries and determined in a central laboratory (Clinical
Trials Service Unit, Oxford). In the pooled sample, the
cohort, sex and energy intake adjusted Pearson‘s partial
correlation coefficients between fruit intake and vitamin
C and beta-carotene plasma concentrations were 0.29
and 0.05, respectively. The correlation coefficients for
vegetable intake were 0.11 and 0.17, respectively.13
Mortality follow-up
Local and regional death registers in Krakow and
Novosibirsk and national death register in the Czech
Republic were used to identify deaths amongst the par-
ticipants. Causes of death were determined using the
9th and 10th revision of the International
Classification of Diseases (ICD): CVD (ICD-9: 390–
459; ICD-10: I00–I99), CHD (410–414; I20–I25),
stroke (430–438; I60–I69). Seventy deceased partici-
pants with no information on the cause of death were
included in the analysis if the outcome was all-cause
mortality but excluded for CVD, CHD and stroke.
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Statistical analysis
Cox proportional hazard model was applied to estimate
the association with all-cause and cause-specific mortal-
ity. F&V intake, categorised into cohort-specific quar-
tiles, was used as the main exposure variable.
Additionally, we also calculated the hazard ratios
(HRs) of mortality per one unit (100 g/day) increase
across six absolute intake categories (<100 g/d, 1–
200 g/d, 2–300 g/d, 3–400 g/d, 4–500 g/d, >500 g/d).
Proportionality assumption was checked using the
Schoenfeld residuals. In model 1, the associations of
F&V intake with mortality were adjusted for sex, age
and cohorts. In model 2, the associations were further
adjusted for education (primary or less, vocational, sec-
ondary, university), household amenities score (number
of household amenities possessed; 0–5: low, 5–7: mod-
erate, 8–12: high), marital status (married/cohabiting,
single/divorced/widowed), alcohol intake (abstainers;
light drinkers: <15 g/day for women, <30 g/day for
men; moderate to heavy drinkers: 15 g/day for
women, 30 g/day for men), smoking (non-, ex-, cur-
rent smokers), physical activity (inactive, moderately
active, active; based on cross-tabulating the sex specific
quartiles of leisure time physical activity expressed in
metabolic equivalent of task (MET)-hours/day with
occupational activity categories), total energy intake
(MJ/day), vitamin supplement intake (no intake, irregu-
lar intake – less than three times a week, regular intake –
at least three times a week) and diet quality (using the
healthy diet indicator (HDI) without the F&V compo-
nent).13 Since the correlation between fruit and vegetable
intake was moderate (Spearman‘s rho¼ 0.21), the HRs
were further adjusted for each other when their associ-
ation with mortality outcomes were examined separately.
The preventable proportion (PP) of deaths which
could be avoided if participants in the lowest three quar-
tiles would shift their intake one quartile upward was
calculated using the same formula as in previous studies.2
Because of a significant interaction between F&V
intake and smoking for all-cause mortality
(p¼ 0.008), we also report results separately by smok-
ing groups. Although we found no significant inter-
action between F&V intake and cohorts, data were
also analysed separately by country cohorts.
In order to assess the mediating effect of blood pres-
sure, the associations were further adjusted for mean
arterial blood pressure (MAP) in the subsample of par-
ticipants who were not taking antihypertensive medica-
tions (n¼ 13,966). MAP was calculated from systolic
blood pressure (SBP) and diastolic blood pressure
(DBP) as follows:14
MAP ¼ 1=3ðSBPÞ þ 2=3ðDBPÞ
To estimate how much of the mortality differences
between cohorts can be explained by F&V intake, age
and sex adjusted HRs of cohort-specific mortality rates
were further adjusted for F&V intake, using the Czech
cohort as reference group and F&V intake as a con-
tinuous variable.
Two sided p-values< 0.05 were used to identify stat-
istical significance. All statistical analysis was carried
out with the statistical software STATA 13.1
(StataCorp, Texas, USA).
Imputation of missing data
At least one variable used in the analysis (marital
status, smoking habits, education, household amenities
score, physical activity, body mass index (BMI), vita-
min supplement intake, MAP or serum cholesterol) had
missing data for 3122 participants (16% of the analyt-
ical sample). We assumed that these data were missing
at random because sensitivity analysis showed that
although the ‘missingness’ was significantly associated
with several covariates in all three country cohorts,
many of these associations became non-significant
when age, sex, smoking and alcohol intake were
adjusted for. Multiple random imputation was carried
out using the ‘mi impute chained’ command in STATA.
Ten imputed datasets were created, and the following
predictor variables were included:15 age, sex, alcohol
intake, total energy intake, F&V intake, follow-up
time and all-cause mortality. The procedure was carried
out separately for each cohort.
Results
The median F&V consumption in the pooled sample
was 426.7 g/day (Supplementary Material, Table S2).
Compared to the other two country cohorts, Russian
participants had substantially lower fruit and total
F&V intakes. Over a mean follow up of 7.1 years,
1314 deaths occurred. Total and CVD (including
CHD and stroke) mortality rates were considerably
higher in the Russian cohort than in the Czech and
Polish samples.
Table 1 shows the distribution of participants’ socio-
demographic and lifestyle characteristics and CVD risk
factors across cohort-specific quartiles of F&V intakes.
Being female, higher education and higher household
amenities score were positively associated with F&V
intake. Those who ate more fruits and vegetables also
seem to have better overall diet, and were less likely to
be heavy drinkers, smokers, or physically inactive.
Among the potential mediators, mean arterial blood
pressure declined but BMI increased and serum choles-
terol level did not change with increasing F&V con-
sumption, which suggests that blood pressure is a
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possible but BMI and cholesterol are unlikely medi-
ators between F&V intake and CVD.
The associations between F&V intake and the mor-
tality outcomes are presented in Table 2. Although
inverse associations were found for all four mortality
outcomes, statistically significant lower mortality risk
in the highest compared to the lowest F&V intake quar-
tiles was found only for stroke after multiple adjust-
ment. The trends were borderline significant for CVD
and stroke, and non-significant for all-cause and CHD
mortality. The PP estimates indicated that if F&V
intake increased by one quartile, the reduction in mor-
tality would be the greatest for stroke (16.3%). When
the effects of fruit and vegetable intakes were analysed
separately, the multivariable adjusted results indicated
inverse but mostly statistically non-significant
associations.
In the subgroup analysis, we found statistically
significant inverse associations between overall F&V
intake and total mortality in current smokers but not
in ex- or never smokers (Table 3). Significantly reduced
CVD and stroke mortality risk in the highest vs lowest
intake quartiles was also found only for smokers. In
cohort-specific analysis, similarly to the pooled
sample, most associations were found to be inverse
but statistically not significant (Supplementary
Material, Table S3).
To assess potential mediating role of blood pressure,
we conducted analysis with and without additional
adjustment for mean arterial blood pressure (MAP)
on a subsample of participants who took no antihyper-
tensive medication at baseline (Table 4). After adjusting
for MAP, HRs increased for all four mortality out-
comes. The reduction in the strength of the association
was largest for CVD (the change in the HR between
highest vs lowest quartile was 37%).
When the associations between cohorts and
mortality rates were adjusted for F&V intake, the
Table 1. Distribution of sample characteristics across cohort-specific fruit and vegetable intake quartiles.
Cohort-specific fruit and vegetable intake quartiles
Q1 Q2 Q3 Q4
F&V intake
Median fruit intake (IQR), g/day 75.2 (36.4–127.1) 170.2 (95.7–246.0) 268.8 (158.0–369.8) 482.3 (306.6–686.7)
Median vegetable intake (IQR), g/day 119.4 (80.3–161.8) 189.4 (138.1–234.1) 247.0 (183.1–318.0) 371.3 (262.6–495.4)
Median fruit and vegetable intake (IQR), g/day 214.1 (165.2–251.3) 352.1 (318.7–412.6) 514.7 (449.1–591.1) 831.4 (698.5–1067.4)
Socio-demographic characteristics
Mean age (SD), years 57.1 (7.1) 57.0 (7.1) 57.1 (7.0) 56.7 (6.8)
Sex, female, % 42.7 51.2 58.5 65.8
Marital status,a married, % 72.2 76.6 76.2 76.5
Education,a primary or less, % 11.2 10.0 10.1 8.6
Education,a university, % 23.3 25.0 25.3 29.3
Household amenities score,a low, % 27.4 21.5 19.5 16.7
Household amenities score,a high, % 28.4 32.5 34.8 38.7
Lifestyle characteristics
Mean energy intake (SD), MJ/day 8.4 (2.6) 9.2 (2.8) 9.8 (2.9) 11.2 (3.3)
Mean HDI score (without F&V component) (SD) 45.3 (8.8) 45.6 (8.4) 46.4 (8.6) 46.2 (8.4)
Median alcohol intake (IQR), g/day 1.9 (0.2–11.0) 1.7 (0.2–8.5) 1.2 (0.2–6.7) 1.0 (0.1–5.7)
Alcohol, moderate to heavy drinkers, % 12.0 9.7 7.6 7.0
Smoking,a current smokers, % 38.6 30.5 27.7 25.9
Physical activity,a low, % 50.1 49.0 48.3 47.6
Vitamin supplement intake, regular, % 13.3 15.4 19.9 22.9
Possible mediators
Mean BMI,a (SD), kg/m2 27.3 (4.7) 27.7 (4.7) 28.0 (4.7) 28.1 (4.8)
BMIa >30 kg/m2, % 24.6 27.7 29.0 30.7
Mean MAP,a (SD), mm Hg 105.5 (15.4) 105.2 (15.2) 104.7 (15.2) 103.8 (14.9)
Hypertension,a,b % 46.9 47.7 47.1 44.8
Mean serum cholesterol level,a (SD), mmol/l 6.0 (1.2) 6.0 (1.2) 6.0 (1.2) 6.0 (1.2)
Hypercholesterolaemia,a,c % 75.4 76.6 77.1 77.5
BMI: body mass index; F&V: fruit and vegetable; HDI: healthy diet indicator; IQR: interquartile range; MAP: mean arterial blood pressure; SD: standard
deviation. aIncluding imputed data; bMAP> 110 mm Hg or on antihypertensive medication; cserum cholesterol level> 5.2 mmol/l or on lipid lowering
medication.
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HRs, which reflect the mortality differences between the
Czech and the other two cohorts, decreased consider-
ably (Table 5).
Discussion
Summary of main findings
In this study in three CEE/FSU populations, total and
CVD mortality was inversely associated with F&V
intake, however, most associations were not statistically
significant. We found that the inverse associations were
stronger among smokers. The impact of F&V con-
sumption was largest for stroke mortality, and the
blood pressure lowering effect of F&V intake appeared
as an important mediator. Finally, our results suggest
that some of the large mortality gap between the Czech
and Russian cohorts might be partially due to the lower
F&V intake in Russia.
Limitations/strengths
Our study has several limitations. The restriction of
study participants to urban adults and the moderate
response rate restricts the generalizability of our find-
ings, and the exclusions of participants due to missing
or implausible data may potentially aggravate the non-
response bias. However, the response rate was similar
to other recent studies in the CEE/FSU region16 and
elsewhere, and sensitivity analyses showed that changes
in the exclusion/inclusion criteria had little impact on
the overall results (data not shown). Although the
Table 2. Results of Cox regression analysis on the pooled sample (n¼ 19,333).
Cohort-specific quartiles
Per 100 g/day increaseaQ1 Q2 Q3 Q4
Cause of
death Deaths/n Model HR HR (95% CI) HR (95% CI) HR (95% CI)
p-value
(trend) PP% HR (95% CI)
Fruit and vegetable intake
All-cause 1314/19,333 Model 1 1.00 ref. 0.78 (0.68–0.90) 0.77 (0.66–0.89) 0.67 (0.58–0.79) <0.001 10.1 0.90 (0.87–0.90)
Model 2 1.00 ref. 0.93 (0.80–1.08) 0.97 (0.83–1.13) 0.91 (0.76–1.08) 0.356 2.4 0.98 (0.94–1.02)
CVD 438/19,263 Model 1 1.00 ref. 0.66 (0.51–0.84) 0.65 (0.51–0.84) 0.54 (0.41–0.72) <0.001 16.1 0.87 (0.81–0.93)
Model 2 1.00 ref. 0.80 (0.62–1.03) 0.83 (0.64–1.09) 0.74 (0.54–1.01) 0.060 7.7 0.95 (0.89–1.02)
CHD 226/19,263 Model 1 1.00 ref. 0.62 (0.44–0.87) 0.61 (0.43–0.87) 0.60 (0.41–0.87) 0.003 14.3 0.87 (0.80–0.96)
Model 2 1.00 ref. 0.79 (0.55–1.13) 0.85 (0.59–1.25) 0.92 (0.60–1.39) 0.608 2.4 0.99 (0.89–1.09)
Stroke 109/19,263 Model 1 1.00 ref. 0.62 (0.37–1.02) 0.69 (0.42–1.13) 0.50 (0.28–0.88) 0.019 17.9 0.88 (0.77–1.00)
Model 2 1.00 ref. 0.67 (0.40–1.12) 0.73 (0.44–1.24) 0.52 (0.28–0.98) 0.056 16.3 0.91 (0.78–1.05)
Fruit intakeb
All–cause 1314/19,333 Model 1 1.00 ref. 0.75 (0.65–0.86) 0.72 (0.62–0.84) 0.68 (0.58–0.79) <0.001 10.2 0.92 (0.88–0.96)
Model 2 1.00 ref. 0.95 (0.82–1.10) 0.97 (0.83–1.13) 0.99 (0.83–1.18) 0.845 0.3 1.00 (0.96–1.04)
CVD 438/19,263 Model 1 1.00 ref. 0.77 (0.61–0.97) 0.55 (0.42–0.72) 0.53 (0.40–0.70) <0.001 16.6 0.84 (0.78–0.91)
Model 2 1.00 ref. 1.00 (0.79–1.28) 0.75 (0.56–0.99) 0.78 (0.57–1.07) 0.034 6.2 0.92 (0.84–0.99)
CHD 226/19,263 Model 1 1.00 ref. 0.67 (0.48–0.94) 0.51 (0.35–0.74) 0.54 (0.36–0.80) <0.001 16.9 0.85 (0.76–0.95)
Model 2 1.00 ref. 0.91 (0.65–1.28) 0.73 (0.49–1.08) 0.86 (0.55–1.33) 0.235 4.0 0.95 (0.85–1.07)
Stroke 109/19,263 Model 1 1.00 ref. 0.90 (0.57–1.43) 0.62 (0.37–1.05) 0.51 (0.28–0.93) 0.011 16.0 0.82 (0.70–0.97)
Model 2 1.00 ref. 1.12 (0.69–1.82) 0.79 (0.45–1.38) 0.66 (0.34–1.29) 0.164 9.4 0.87 (0.73–1.03)
Vegetable intakeb
All-cause 1314/19,333 Model 1 1.00 ref. 0.76 (0.65–0.88) 0.75 (0.65–0.87) 0.72 (0.62–0.83) <0.001 8.8 0.93 (0.89–0.97)
Model 2 1.00 ref. 0.82 (0.70–0.95) 0.84 (0.72–0.98) 0.85 (0.72–1.00) 0.052 4.4 0.98 (0.93–1.03)
CVD 438/19,263 Model 1 1.00 ref. 0.83 (0.65–1.06) 0.69 (0.53–0.89) 0.67 (0.51–0.88) <0.001 10.3 0.90 (0.84–0.98)
Model 2 1.00 ref. 0.93 (0.72–1.20) 0.81 (0.62–1.07) 0.88 (0.66–1.19) 0.249 3.2 0.99 (0.90–1.07)
CHD 226/19,263 Model 1 1.00 ref. 0.81 (0.58–1.15) 0.65 (0.45–0.94) 0.71 (0.49–1.02) 0.027 9.2 0.91 (0.82–1.01)
Model 2 1.00 ref. 0.94 (0.66–1.34) 0.82 (0.55–1.20) 1.00 (0.66–1.51) 0.745 0.0 1.01 (0.89–1.14)
Stroke 109/19,263 Model 1 1.00 ref. 0.73 (0.44–1.21) 0.64 (0.38–1.08) 0.64 (0.38–1.07) 0.066 12.1 0.91 (0.78–1.06)
Model 2 1.00 ref. 0.76 (0.45–1.26) 0.65 (0.38–1.13) 0.69 (0.39–1.24) 0.157 10.0 0.94 (0.79–1.12)
CI: confidence interval; CHD: coronary heart disease; CVD: cardiovascular disease; HDI: healthy diet indicator; HR: hazard ratio; PP: preventable
proportion. Model 1: adjusted for sex, age, cohort. Model 2: adjusted for sex, age, cohort, alcohol intake, smoking, education, household amenities
score, marital status, energy intake, physical activity, vitamin supplement intake, HDI (without F&V component), fruit/vegetable intake. aPer one unit
increase across six intake categories (<100 g/d, 1–200 g/d, 2–300 g/d, 300–400 g/d, 400–500 g/d, >500 g/d). bIn model 2, fruit and vegetable intakes
were mutually adjusted for each other.
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results may not be entirely applicable to the Czech,
Polish and Russian populations as a whole, this limita-
tion does not affect the results regarding the association
between F&V intake and mortality outcomes.
A well-known disadvantage of the FFQ is that
it tends to over-estimate F&V intake.17 If the extent
of over-reporting is larger in those with low actual
F&V intake, then the variation in reported F&V
intake is reduced and effect estimates are under-esti-
mated. This is consistent with the biomarker validation
results, which suggested that the misreporting of F&V
intake was largest amongst Polish participants,13 the
cohort in which the association of F&V intake with
total and CVD mortality was the weakest. This might
Table 3. Results of Cox regression analysis by smoking groups.
Cohort-specific fruit and vegetable intake quartiles
Per 100 g/day increaseaQ1 Q2 Q3 Q4
Cause of
death Subgroup Deaths/n HR HR (95% CI) HR (95% CI) HR (95% CI)
p-value
(trend) PP% HR (95% CI)
All-cause Current smokers 638/5905 1.00 ref. 0.90 (0.73–1.11) 0.87 (0.70–1.09) 0.70 (0.53–0.91) 0.011 8.8 0.93 (0.87–0.98)
Ex-smokers 300/4080 1.00 ref. 0.94 (0.69–1.28) 0.93 (0.67–1.29) 1.09 (0.76–1.57) 0.748 2.3 1.00 (0.92–1.10)
Never smokers 369/9272 1.00 ref. 1.02 (0.76–1.38) 1.22 (0.91–1.66) 1.20 (0.86–1.67) 0.168 4.5 1.05 (0.97–1.14)
CVD Current smokers 226/5871 1.00 ref. 0.75 (0.53–1.06) 0.78 (0.54–1.14) 0.62 (0.40–0.97) 0.037 11.9 0.94 (0.85–1.04)
Ex-smokers 94/4062 1.00 ref. 0.93 (0.55–1.57) 0.71 (0.39–1.32) 1.06 (0.55–2.03) 0.782 1.6 0.92 (0.79–1.08)
Never smokers 117/9254 1.00 ref. 0.79 (0.47–1.32) 1.06 (0.64–1.77) 0.80 (0.44–1.45) 0.747 5.5 1.01 (0.87–1.16)
CHD Current smokers 125/5871 1.00 ref. 0.72 (0.44–1.16) 0.82 (0.50–1.37) 0.76 (0.43–1.35) 0.340 7.3 0.98 (0.86–1.12)
Ex-smokers 49/4062 1.00 ref. 1.07 (0.52–2.20) 0.52 (0.20–1.37) 1.48 (0.63–3.47) 0.828 11.9 0.91 (0.73–1.13)
Never smokers 51/9254 1.00 ref. 0.76 (0.34–1.71) 1.32 (0.62–2.85) 0.97 (0.39–2.40) 0.710 0.8 1.10 (0.88–1.37)
Stroke Current smokers 50/5871 1.00 ref. 0.76 (0.37–1.56) 0.66 (0.30–1.46) 0.30 (0.10–0.94) 0.038 25.6 0.85 (0.68–1.06)
Ex-smokers 18/4062 1.00 ref. 0.70 (0.15–3.23) 1.86 (0.49–7.00) 2.09 (0.49–8.87) 0.172 19.3 1.34 (0.91–1.98)
Never smokers 41/9254 1.00 ref. 0.55 (0.23–1.30) 0.57 (0.24–1.34) 0.43 (0.16–1.17) 0.110 22.1 0.85 (0.66–1.08)
CI: confidence interval; CHD: coronary heart disease; CVD: cardiovascular disease; HDI: healthy diet indicator; HR: hazard ratio; PP: preventable
proportion. All HRs are adjusted for sex, age, cohort, alcohol intake, education, household amenities score, marital status, energy intake, physical activ-
ity, vitamin supplement intake, HDI (without F&V component). aPer one unit increase across six intake categories (<100 g/d, 100–200 g/d, 200–300 g/d,
300–400 g/d, 400–500 g/d, >500 g/d).
Table 4. Results of Cox regression analysis before and after adjustment for mean arterial blood pressure (MAP) on a subsample of
participants who took no antihypertensive medications (n¼ 13,966).
Cohort-specific fruit and vegetable intake quartiles
Per 100 g/day increaseaQ1 Q2 Q3 Q4
Cause of death Deaths/n Model HR HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
All-cause 939/13, 966 Model 1 1.00 ref. 0.92 (0.77–1.09) 0.94 (0.78–1.13) 0.88 (0.71–1.08) 0.95 (0.91–1.00)
Model 2 1.00 ref. 0.92 (0.77–1.09) 0.96 (0.80–1.15) 0.90 (0.73–1.11) 0.96 (0.91–1.01)
Percentage changeb (%) 0 33.3 16.7 20.0
CVD 305/13, 915 Model 1 1.00 ref. 0.79 (0.58–1.07) 0.76 (0.55–1.06) 0.81 (0.56–1.17) 0.94 (0.87–1.03)
Model 2 1.00 ref. 0.81 (0.60–1.10) 0.80 (0.58–1.12) 0.88 (0.61–1.28) 0.96 (0.88–1.05)
Percentage changeb (%) 9.5 16.7 36.8 33.3
CHD 175/13, 915 Model 1 1.00 ref. 0.71 (0.47–1.07) 0.76 (0.49–1.18) 0.99 (0.62–1.57) 0.98 (0.87–1.10)
Model 2 1.00 ref. 0.73 (0.49–1.11) 0.80 (0.51–1.24) 1.07 (0.67–1.71) 1.00 (0.89–1.12)
Percentage changeb (%) 6.9 16.7 na 100.0
Stroke 65/13 915 Model 1 1.00 ref. 0.81 (0.43–1.53) 0.66 (0.32–1.34) 0.53 (0.23–1.22) 0.86 (0.71–1.05)
Model 2 1.00 ref. 0.85 (0.45–1.60) 0.72 (0.35–1.48) 0.62 (0.26–1.44) 0.89 (0.73–1.08)
Percentage changeb (%) 21.1 17.6 19.1 21.4
CI: confidence interval; CHD: coronary heart disease; CVD: cardiovascular disease; HDI: healthy diet indicator; HR: hazard ratio; na: not applicable;
PP: preventable proportion. Model 1: adjusted for sex, age, cohort, alcohol intake, smoking, education, household amenities score, marital status,
energy intake, physical activity, vitamin supplement Intake, HDI (without F&V component). Model 2: adjusted for all covariates in model 1þMAP.
aPer one unit increase across six intake categories (<100 g/d, 100–200 g/d, 200–300 g/d, 300–400 g/d, 400–500 g/d, >500 g/d) b% change¼ (HR2–HR1)/
(1–HR1)*100.
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help explain the lack of strong associations on the
pooled sample.
We cannot exclude the possibility that unmeasured
socio-economic or lifestyle factors may have affected
(and confounded) the associations. However, the fact
that we adjusted for a large number of possible con-
founders, including the healthy diet indicator (taking
into account other dietary factors), reduced the possi-
bility of residual confounding.
On the other hand, the large sample size, the pro-
spective design and the substantial variation of F&V
intake both within and between cohorts are important
strengths and make this study unique in the research on
mortality in CEE/FSU to date.
Consistency with other studies
The most recent meta-analysis found that the pooled
HRs (95% CIs) of all-cause and CVD mortality per one
serving/day increase in F&V intake was 0.95 (0.92–
0.98) and 0.96 (0.92–0.99), respectively.18 This meta-
analysis and previous studies indicated similar effects
for CHD and stroke and for the associations with
fruits and vegetables separately.3,4,18 Our results in
the pooled HAPIEE sample suggest somewhat weaker
link for many intake-outcome pairs, which can be due
to the relatively short follow-up time, insufficient stat-
istical power, and potential misclassification of F&V
intake.19
We found that the inverse association between F&V
intake and mortality was significantly stronger in cur-
rent smokers compared to non-smokers, suggesting that
smokers would benefit the most if their F&V
consumption was increased. Similar effect of F&V
intake in smokers has been described in several,20,21
but not all,22 previous studies. There are a number of
possible explanations for this interaction. For example,
as smokers are subject of increased levels of oxidative
stress, the protective effect of antioxidants in F&Vmight
be more pronounced for them compared to non-
smokers. However, the lack of association between anti-
oxidant vitamins and health outcomes in experimental
trials does not support this hypothesis.23 F&V contain
large amounts of polyphenols as well, and their vasodila-
tor, anti-inflammatory and antithrombotic effects
can also counteract the harmful effects of tobacco
smoke.24 On the other hand, we cannot exclude the
possibility of residual confounding, however, when we
further adjusted the results for the number of cigarettes
smoked per day and the number of years have smoked,
the associations remained statistically significant.
The proportion of deaths, which could be prevented
if the intake of F&V increased in the population, was
higher in our study than in recently published report in
Western European populations.2 This seems to indicate
that the burden of disease, in particular CVD, due to
inadequate F&V intake may be higher in Eastern
European countries than in Western Europe, consistent
with the Burden of Disease calculations.9 Further
research, using comparable dietary assessment methods
in Eastern and Western European samples, would be
needed to clarify this question.
The finding that F&V intake was related to
decreased blood pressure, which, in turn, contributed
to the CVD risk reduction, has been reported in a
number of observational and interventional
Table 5. Hazard ratios of cohort differences in all-cause, cardiovascular disease (CVD), coronary heart disease (CHD) and stroke
mortality with and without adjustment for fruit and vegetable intake.
Cause of death Cohort
Model 1 Model 2
Percentage change (%)aHR (95% CI) HR (95% CI)
All-cause Czech 1.0 1.0
Polish 1.22 (1.05–1.42) 1.21 (1.04–1.40) 4.5
Russian 1.91 (1.66–2.19) 1.82 (1.58–2.10) 9.9
CVD Czech 1.0 1.0
Polish 1.14 (0.86–1.51) 1.11 (0.84–1.48) 21.4
Russian 2.87 (2.25–3.68) 2.62 (2.04–3.36) 13.4
CHD Czech 1.0 1.0
Polish 1.23 (0.80–1.90) 1.21 (0.79–1.87) 8.7
Russian 4.13 (2.87–5.96) 3.86 (2.67–5.60) 8.6
Stroke Czech 1.0 1.0
Polish 1.26 (0.66–2.42) 1.22 (0.64–2.35) 15.4
Russian 4.70 (2.74–8.04) 4.15 (2.40–7.16) 14.9
CI: confidence interval; F&V: fruit and vegetable; HR: hazard ratio. Model 1: adjusted for age, sex. Model 2: adjusted for age, sex, F&V intake
(as continuous variable). aPercentage change¼ (HR1–HR2)/(HR1–1)*100.
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studies.1,6,25 This pathway could be involved in the
stronger inverse association of F&V intake with stroke
compared to CHD. Although the mechanism how F&V
intake reduces blood pressure is not entirely clear, the
evidence regarding the antihypertensive effects of potas-
sium and magnesium compounds of F&V seems fairly
strong,26 and some authors also suggest that antioxi-
dants might affect arterial stiffness too.27
The low and declining F&V consumption in Russia
and other FSU countries was described by Abe and
colleagues.28 Our study confirmed lower F&V intakes
in Russia compared to two Central and Eastern
European populations, and the results support the
plausible hypothesis that low intakes of F&V might
contribute to high CVD mortality in this country.
Further studies are needed to explore the specific rea-
sons for the inadequate F&V intake in Russia, and to
identify population-based preventative strategies that
would be the most effective.29
Reducing alcohol consumption and tobacco smok-
ing need to be the focus of any public health interven-
tion campaigns in CEE and FSU which aim to decrease
the CVD burden of the population.30 The recommen-
dation to increase F&V consumption could comple-
ment these main targets well, and could be highly
beneficial, especially for smokers and hypertensive
individuals.
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